Mallinckrodt is seeking to postpone a $200 million opioid settlement payment, Bloomberg News reported on Thursday citing people with knowledge of the matter.
The drugmaker wants lenders to waive off provisions that would make Mallinckrodt a defaulter if it skipped the opioid payment due June 16, the report said.
Mallinckrodt did not immediately respond to request for comment.
The company earlier this month said it was considering a second bankruptcy filing and other options after its lenders raised concerns over the $200 million payment.
Mallinckrodt emerged from bankruptcy last year after winning court approval for a reorganization plan that included a $1.7 billion settlement of the litigation.